Sugi Predict

Sugi Predict / Compounds / Indocyanine Green Acid Form

Indocyanine Green Acid Form

Indocyanine Green Acid Form

SCHEMBL9976691

CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccc3ccccc3c21

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MLNR O43193 1/20 0.93
▸ NR1I2 O75469 1/20 0.93
▸ PGR P06401 1/20 0.93
▸ ADRB1 P08588 1/20 0.93
▸ ADORA3 P0DMS8 1/20 0.93
▸ CHRM1 P11229 1/20 0.93
▸ DRD2 P14416 1/20 0.93
▸ ADRA2B P18089 1/20 0.93
▸ ADRA2C P18825 1/20 0.93
▸ CHRM3 P20309 1/20 0.93
▸ CNR1 P21554 1/20 0.93
▸ DRD1 P21728 1/20 0.93
▸ TBXA2R P21731 1/20 0.93
▸ SLC6A2 P23975 1/20 0.93
▸ HRH2 P25021 1/20 0.93
▸ HTR2C P28335 1/20 0.93
▸ BDKRB2 P30411 1/20 0.93
▸ ADORA1 P30542 1/20 0.93
▸ AGTR1 P30556 1/20 0.93
▸ SLC6A4 P31645 1/20 0.93

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Indocyanine Green Acid Form SCHEMBL29714259 1.00 MLNR (0.93) MLNRNR1I2PGRADRB1ADORA3
SCHEMBL13127982 1.00 MLNR (0.93) MLNRNR1I2PGRADRB1ADORA3
Indocyanine Green Acid Form SCHEMBL30735698 1.00 MLNR (0.93) MLNRNR1I2PGRADRB1ADORA3
Indocyanine Green Acid Form SCHEMBL12891571 1.00 MLNR (0.93) MLNRNR1I2PGRADRB1ADORA3
SCHEMBL15182433 1.00 MLNR (0.93) MLNRNR1I2PGRADRB1ADORA3
Indocyanine Green Acid Form SCHEMBL15929439 1.00 MLNR (0.93) MLNRNR1I2PGRADRB1ADORA3
Indocyanine Green Acid Form SCHEMBL14198523 1.00 MLNR (0.93) MLNRNR1I2PGRADRB1ADORA3
Indocyanine Green Acid Form SCHEMBL1783237 0.99 MLNR (0.91) MLNRNR1I2PGRADRB1ADORA3
Indocyanine Green Acid Form SCHEMBL10626491 0.99 MLNR (0.91) MLNRNR1I2PGRADRB1ADORA3
Indocyanine Green Acid Form SCHEMBL1783239 0.99 MLNR (0.91) MLNRNR1I2PGRADRB1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144876-A1 TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2026-05-28 — — US disclosed
US-12478677-B2 Tunable luminescent organic salts for enhanced imaging and photodynamic therapy BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2025-11-25 — — US disclosed
WO-2023009833-A9 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2023-11-23 — — WO disclosed
US-20200230238-A1 TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2020-07-23 — — US disclosed
US-10041937-B2 Macrophage identification agent, and identification method, sorting method, evaluation method, screening method and kit using the macrophage identifier agent CANON KABUSHIKI KAISHA (JP) 2018-08-07 — — US disclosed
US-20170112948-A1 Inorganic-organic hybrid compound Karlsruher Institut für Technologie (DE) 2017-04-27 — — US disclosed
WO-2016181304-A1 COPOLYMER COMPOSITIONS AND USES THEREOF ETH Zürich (CH) 2016-11-17 — — WO disclosed
EP-3093027-A1 COPOLYMER COMPOSITIONS AND USES THEREOF ETH Zurich (CH) 2016-11-16 — — EP disclosed
US-20160018389-A1 MACROPHAGE IDENTIFICATION AGENT, AND IDENTIFICATION METHOD, SORTING METHOD, EVALUATION METHOD, SCREENING METHOD AND KIT USING THE MACROPHAGE IDENTIFIER AGENT CANON KABUSHIKI KAISHA (JP) 2016-01-21 — — US disclosed
US-20160018389-A1 MACROPHAGE IDENTIFICATION AGENT, AND IDENTIFICATION METHOD, SORTING METHOD, EVALUATION METHOD, SCREENING METHOD AND KIT USING THE MACROPHAGE IDENTIFIER AGENT CANON KABUSHIKI KAISHA (JP) 2016-01-21 — — US disclosed
US-8270060-B2 Infrared ray transmittance controlling panel including color modifying layer SAMSUNG SDI CO., LTD. (KR) 2012-09-18 — — US disclosed
US-20120156311-A1 COMBINATION THERAPY FOR CANCER COMPRISING A PLATINUM-BASED ANTINEOPLASTIC AGENT AND A BIOCOMPATIBLE ELECTRON DONOR Lu qing-bin (CA) 2012-06-21 — — US disclosed
US-20110123450-A1 MACROCYCLIC CYANINE AND INDOCYANINE BIOCONJUGATES PROVIDE IMPROVED BIOMEDICAL APPLICATION THE WASHINGTON UNIVERSITY (US) 2011-05-26 — — US disclosed
US-20110075243-A1 INFRARED RAY TRANSMITTANCE CONTROLLING PANEL INCLUDING COLOR MODIFYING LAYER SAMSUNG SDI CO., LTD. (KR) 2011-03-31 — — US disclosed
US-7869030-B2 Aggregates of plural transition metal nanoparticles and plural cyanine dye molecules RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2011-01-11 — — US disclosed
US-7869030-B2 Aggregates of plural transition metal nanoparticles and plural cyanine dye molecules RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2011-01-11 — — US disclosed
US-20100034748-A1 Molecular imaging probes based on loaded reactive nano-scale latex QUANTUM MEDICAL HOLDINGS, LLC 2010-02-11 — — US disclosed
US-20080316480-A1 AGGREGATES OF PLURAL TRANSITION METAL NANOPARTICLES AND PLURAL CYANINE DYE MOLECULES RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2008-12-25 — — US disclosed
US-20080316480-A1 AGGREGATES OF PLURAL TRANSITION METAL NANOPARTICLES AND PLURAL CYANINE DYE MOLECULES RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2008-12-25 — — US disclosed
US-20080181965-A1 Loaded latex optical molecular imaging probes QUANTUM MEDICAL HOLDINGS, LLC 2008-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080181965-A1 Loaded latex optical molecular imaging probes MLX, LOXL1, EPX MLNR 324/4885NR1I2 2630/4885PGR 2104/4885
US-20100034748-A1 Molecular imaging probes based on loaded reactive nano-scale latex CLTA, COPE, CD68 MLNR 910/4885NR1I2 3011/4885PGR 3270/4885
US-10041937-B2 Macrophage identification agent, and identification method, sorting method, evaluation method, screening method and kit using the macrophage identifier agent CD68, MSR1, MYADM MLNR 361/4885NR1I2 290/4885PGR 3210/4885
US-20120156311-A1 COMBINATION THERAPY FOR CANCER COMPRISING A PLATINUM-BASED ANTINEOPLASTIC AGENT AND A BIOCOMPATIBLE ELECTRON DONOR NQO1, IDH2, SLC25A1 MLNR 2545/4885NR1I2 2553/4885PGR 331/4885
US-20170112948-A1 Inorganic-organic hybrid compound SLCO4C1, SLCO2A1, SLCO1A2 MLNR 2173/4885NR1I2 1802/4885PGR 1842/4885
US-20260144876-A1 TUNABLE LUMINESCENT ORGANIC SALTS FOR ENHANCED IMAGING AND PHOTODYNAMIC THERAPY SLC10A6, ACTB, SLC6A6 MLNR 2179/4885NR1I2 3022/4885PGR 2112/4885
US-20110123450-A1 MACROCYCLIC CYANINE AND INDOCYANINE BIOCONJUGATES PROVIDE IMPROVED BIOMEDICAL APPLICATION HCCS, CRY2, CRY1 MLNR 519/4885NR1I2 740/4885PGR 3997/4885
US-20160018389-A1 MACROPHAGE IDENTIFICATION AGENT, AND IDENTIFICATION METHOD, SORTING METHOD, EVALUATION METHOD, SCREENING METHOD AND KIT USING THE MACROPHAGE IDENTIFIER AGENT CD68, MSR1, MYADM MLNR 361/4885NR1I2 290/4885PGR 3210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.